Under the "Make in India" initiative, India and the Netherlands signed a memorandum of understanding enabling Bharat Immunologicals and Biologicals, a public-sector biotech under India's department of biotechnology, to develop a measles and rubella vaccine with the assistance of the Netherlands' government-based Translational Vaccinology. Bharat Immunologicals, established in 1989, aims at achieving self-sufficiency for India's production and supply of polio vaccines and other biologicals. The agreement is hoped to bring about large-scale production of the vaccine and others in India. More